P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL

Bibliographic Details
Main Authors: David Ross, Devendra Hiwase, Steven Lane, Kirsty Sharplin, Agnes Yong, Yeung David, Dale Chappell, Cameron Durrant, Timothy Hughes, Daniel Thomas
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000969852.23114.6d
_version_ 1797280805627625472
author David Ross
Devendra Hiwase
Steven Lane
Kirsty Sharplin
Agnes Yong
Yeung David
Dale Chappell
Cameron Durrant
Timothy Hughes
Daniel Thomas
author_facet David Ross
Devendra Hiwase
Steven Lane
Kirsty Sharplin
Agnes Yong
Yeung David
Dale Chappell
Cameron Durrant
Timothy Hughes
Daniel Thomas
author_sort David Ross
collection DOAJ
first_indexed 2024-03-07T16:46:28Z
format Article
id doaj.art-b02e569c1a13481b8355465a3fe13b10
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:46:28Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-b02e569c1a13481b8355465a3fe13b102024-03-03T06:25:17ZengWileyHemaSphere2572-92412023-08-017e231146d10.1097/01.HS9.0000969852.23114.6d202308003-00637P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIALDavid Ross0Devendra Hiwase1Steven Lane2Kirsty Sharplin3Agnes Yong4Yeung David5Dale Chappell6Cameron Durrant7Timothy Hughes8Daniel Thomas91 South Australian Health & Medical Research Institute, Adelaide, Australia1 South Australian Health & Medical Research Institute, Adelaide, Australia2 Queensland Institute of Medical Research, Brisbane, Australia1 South Australian Health & Medical Research Institute, Adelaide, Australia3 Royal Perth Hospital, Perth, Australia1 South Australian Health & Medical Research Institute, Adelaide, Australia4 Humanigen, Inc, Short Hills, NJ, United States4 Humanigen, Inc, Short Hills, NJ, United States1 South Australian Health & Medical Research Institute, Adelaide, Australia1 South Australian Health & Medical Research Institute, Adelaide, Australiahttp://journals.lww.com/10.1097/01.HS9.0000969852.23114.6d
spellingShingle David Ross
Devendra Hiwase
Steven Lane
Kirsty Sharplin
Agnes Yong
Yeung David
Dale Chappell
Cameron Durrant
Timothy Hughes
Daniel Thomas
P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL
HemaSphere
title P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL
title_full P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL
title_fullStr P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL
title_full_unstemmed P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL
title_short P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL
title_sort p737 lenzilumab and azacitidine improve hematologic alterations of chronic myelomonocytic leukemia in the preach m trial
url http://journals.lww.com/10.1097/01.HS9.0000969852.23114.6d
work_keys_str_mv AT davidross p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial
AT devendrahiwase p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial
AT stevenlane p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial
AT kirstysharplin p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial
AT agnesyong p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial
AT yeungdavid p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial
AT dalechappell p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial
AT camerondurrant p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial
AT timothyhughes p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial
AT danielthomas p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial